Money view IPO GMP

Money view IPO GMP: Latest Grey Market Premium, Price Band, Dates and What Investors Should Know

Description: Money view IPO GMP is attracting attention ahead of the October 2026 listing. Check the latest GMP, IPO price band, lot size, subscription details, key dates and important risks before applying.

The Money view IPO GMP has become a closely watched figure among investors as the fintech company moves towards its stock-market debut. Moneyview’s IPO opened for subscription on 24 September 2026 and is scheduled to close on 28 September, with listing planned for 1 October. The issue has a price band of ₹32 to ₹34 per share and a lot size of 441 shares.

Grey market premium, or GMP, is often used by IPO investors as an informal indication of market sentiment before a company's shares begin trading on the exchanges. However, it is not an official exchange price and should not be treated as a guaranteed listing-price indicator.

Money view IPO GMP Today

As of 28 September 2026, several IPO-tracking sources are reporting a Moneyview GMP of around ₹14 per share. IPO Guru's latest recorded figure shows ₹14, equivalent to about 41.18% of the ₹34 upper price band.

Using the simple GMP calculation, an indicative listing price would be:

₹34 issue price + ₹14 GMP = ₹48 per share

This calculation is only an illustration based on the unofficial grey-market figure. It does not mean that Moneyview shares will necessarily list at ₹48. GMP can change before listing, while the actual opening price is determined by buying and selling on the stock exchange.

Money view IPO GMP Trend

The recent movement in the grey market has attracted attention. IPO Guru's reported daily figures show GMP moving from ₹5 on 21 September to ₹11 on 22 September, ₹14 on 23 September, ₹15.5 on 24 September and then around ₹14 in the latest readings.

Another IPO-tracking source also reports a latest GMP of ₹14, while showing a recent range between ₹0 and ₹15.5. The differences between websites are a reminder that grey-market information is informal and can vary according to the source and time of the update.

For readers following Moneyview IPO GMP, the trend may therefore be more useful than looking at one isolated number. A changing premium can reflect changing sentiment, but it does not provide certainty about the eventual listing performance.

Moneyview IPO Price Band and Lot Size

The IPO has a price band of ₹32 to ₹34 per share. The minimum application consists of 441 shares. At the upper price of ₹34, one lot requires an investment of approximately ₹14,994.

Here are the key details:

Particular	Moneyview IPO Details
IPO	Moneyview Limited
Price Band	₹32–₹34
Lot Size	441 shares
Minimum Investment	₹14,994
Issue Size	₹1,091.68 crore
Fresh Issue	₹750 crore
Offer for Sale	₹341.68 crore
IPO Opens	24 September 2026
IPO Closes	28 September 2026
Allotment	29 September 2026
Listing	1 October 2026

The issue comprises a fresh issue of ₹750 crore and an offer for sale worth ₹341.68 crore.

What Does Money view Do?

Money view operates in India's digital financial-services space. Its platform connects consumers with financial products and lending partners. According to IPO information available through Groww, the company's offerings include personal loans, credit cards, earned wage access, home loans, loans against property, insurance, digital gold, UPI transactions and bill payments.

The company has therefore built a business around digital access to financial products rather than operating simply as a traditional lender.

Moneyview's IPO comes at a time when digital financial services continue to attract attention from investors. At the same time, fintech companies can face significant competition, regulatory changes and credit-related risks, which investors should consider alongside headline GMP figures.

Money view IPO Subscription Status

Subscription data is another factor investors are watching closely. As reported by IPO-tracking platforms, the issue had received substantial demand from non-institutional and retail investors during the bidding period. One source recorded total subscription of 6.01 times as of 25 September, with QIB subscription at 0.25 times, NII at 15.41 times and retail at 5.18 times.

Subscription numbers can change significantly during the final day of an IPO. Therefore, figures reported before the issue closes should not be treated as final.

The difference between investor categories is also worth noticing. Strong NII demand does not automatically translate into the same level of institutional demand, and each category follows its own allocation rules.

How Is IPO GMP Calculated?

GMP stands for Grey Market Premium. It represents the premium at which an IPO share is reportedly being traded in the informal market before official stock-exchange listing.

For example, if an IPO's upper issue price is ₹34 and the reported GMP is ₹14, the commonly used calculation is:

₹34 + ₹14 = ₹48 indicative price

The percentage premium can then be calculated as:

₹14 ÷ ₹34 × 100 = 41.18%

This is why websites reporting the latest Moneyview IPO GMP may show an indicative listing value of around ₹48 when the GMP is ₹14.

However, the calculation should not be confused with a guaranteed return. The grey market is unofficial and unregulated, and the GMP may change several times before listing.

Money view IPO Important Dates

The IPO opened on 24 September 2026 and closes on 28 September 2026. The basis of allotment is scheduled for 29 September, while refunds and demat credit are expected on 30 September. The proposed listing date is 1 October 2026.

Investors should check the final information from the relevant exchange, registrar and IPO documents because IPO schedules can be subject to change.

The registrar listed for the issue is MUFG Intime India Pvt. Ltd.

Should Investors Rely Only on Money view IPO GMP?

This is perhaps the most important question for anyone following the IPO.

GMP can provide an indication of informal market sentiment, but it should not be used on its own to assess a company's long-term prospects. A high GMP can fall quickly, while a relatively low GMP does not necessarily mean a company's future stock-market performance will be weak.

Investors should also examine the company's financial performance, business model, valuation, competitive environment, use of IPO proceeds and risk factors mentioned in the offer document.

Recent reports have also highlighted a one-time ₹160 crore performance-linked incentive paid to Moneyview's CEO in FY26, which affected reported profit for that year. This is a specific item that investors may wish to understand when reading the company's financial disclosures.

Money view IPO: What Investors Should Watch

There are several points worth keeping in mind before making an IPO application.

First, watch the GMP trend rather than one number. The premium has moved noticeably during the days leading up to the issue closing.

Second, check the final subscription figures. Demand from QIBs, NIIs and retail investors can provide different signals about the issue.

Third, read the RHP. The red herring prospectus contains detailed information about the company's operations, financials, risks and use of funds.

Fourth, remember that listing price and long-term performance are different things. Even if an IPO opens above its issue price, the share price can subsequently move in either direction.

Money view IPO GMP: Final Takeaway

The Money view IPO GMP is currently being reported at around ₹14 by several tracking sources as of 28 September 2026. Against the ₹34 upper price band, this gives an unofficial indicative listing calculation of around ₹48 per share.

Money view's ₹1,091.68 crore IPO has a price band of ₹32–₹34, a 441-share lot size and a proposed listing date of 1 October 2026.

Still, GMP is not an official NSE or BSE price and does not guarantee listing gains. Investors should consider the company's financial position, valuation, business risks and IPO documents rather than making a decision based solely on the grey market.

Disclaimer: IPO GMP figures are unofficial and can change rapidly. The indicative listing price discussed above is a mathematical calculation based on reported GMP and is not a prediction or guarantee. Investors should read the official offer documents and consider their own financial circumstances before making investment decisions.